Hexagon Nutrition Limited
Hexagon Nutrition Limited (HEXAGON) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
hexagonnutrition.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 | Jun 2026 |
|---|---|---|
| Sales | 115 Cr | 104 Cr |
| Operating expenses (approx.) | 100 Cr | 93 Cr |
| EBITDA | 15 Cr | 12 Cr |
| OPM % | 13.1% | 11.3% |
| Other income | 4 Cr | 2 Cr |
| Interest | 1 Cr | 0.98 Cr |
| Depreciation | 3 Cr | 2 Cr |
| Profit before tax | 15 Cr | 11 Cr |
| Tax % | 29.3% | 23.8% |
| Net profit | 11 Cr | 8 Cr |
| EPS (₹) | ₹0.99 | ₹0.67 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 383 Cr | Sign in for TTM |
| Operating expenses (approx.) | 330 Cr | Sign in for TTM |
| EBITDA | 53 Cr | Sign in for TTM |
| OPM % | 13.7% | Sign in for TTM |
| Other income | 12 Cr | Sign in for TTM |
| Interest | 4 Cr | Sign in for TTM |
| Depreciation | 10 Cr | Sign in for TTM |
| Profit before tax | 51 Cr | Sign in for TTM |
| Tax % | 25.9% | Sign in for TTM |
| Net profit | 38 Cr | Sign in for TTM |
| EPS (₹) | ₹3.43 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 11 Cr |
| Reserves | 222 Cr |
| Borrowings | 30 Cr |
| Other liabilities | 55 Cr |
| Total liabilities | 318 Cr |
| Fixed assets (net) | 61 Cr |
| CWIP | 3 Cr |
| Investments | 37 Cr |
| Inventories | 84 Cr |
| Trade receivables | 82 Cr |
| Cash & bank | 16 Cr |
| Other assets | 36 Cr |
| Total assets | 318 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 6 Cr |
| Cash from investing | -6 Cr |
| Cash from financing | -0.42 Cr |
| Net cash flow | 0.55 Cr |
| Free cash flow (OCF − Capex) | -1 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 20.9% |
| ROE % | 16.3% |
| Debtor days | 78 |
| Inventory days | 151 |
| Days payable | 52 |
| Cash conversion cycle | 177 |
| Debt / equity | 0.13 |
| Current ratio | 3.38 |
| Net debt / EBITDA | 0.28 |